ISSN 1016-5169 | E-ISSN 1308-4488
pdf
Aspirin resistance [Turk Kardiyol Dern Ars]
Turk Kardiyol Dern Ars. 2005; 33(8): 480-487

Aspirin resistance

Erdal Aktürk1, Ergün Topal1, Yüksel Aksoy1

Although aspirin is the most commonly used antithrombotic drug in the treatment of cardiovascular diseases, the appearance of vascular thromboembolic events in some patients receiving aspirin has brought into question its safety and development of aspirin resistance. This article reviews the most current information concerning the cause of aspirin resistance and clinical results and discusses therapeutic implications.

Keywords: Aspirin/pharmacology/therapeutic use/adverse effects; cardiovascular diseases/drug therapy; drug resistance; platelet aggregation/drug effects

How to cite this article
Erdal Aktürk, Ergün Topal, Yüksel Aksoy. Aspirin resistance. Turk Kardiyol Dern Ars. 2005; 33(8): 480-487
Manuscript Language: Turkish


Journal Metrics

Journal Citation Indicator: 0.18
CiteScore: 1.1
Source Normalized Impact
per Paper:
0.22
SCImago Journal Rank: 0.348

Quick Search



Copyright © 2024 Archives of the Turkish Society of Cardiology



Kare Publishing is a subsidiary of Kare Media.